Angel News

p2p banner

Back to Homepage

25th September 2017

Maven Capital Partners is leading an investment in ADC Biotechnology  to support the construction of a dedicated pharmaceutical manufacturing facility at a site in Deeside, North Wales, creating 50 new scientific jobs.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage